MedTrace Logo

Hydroxychloroquine in Cystic Fibrosis

NCT00311883 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-01-30

No results posted yet for this study

Summary

Study levels of inflammatory mediators in induced sputum of patients with cystic fibrosis before and after a 4 week course of oral hydroxychloroquine.

Conditions

Interventions

DRUG

hydroxychloroquine

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Bonnie S Slovis, MD · Vanderbilt University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00311883 on ClinicalTrials.gov